Petros Efthimiou

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. ncbi request reprint Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005
  2. doi request reprint Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature
    Petros Efthimiou
    Section of Rheumatology, Lincoln Medical and Mental Health Center, New York, NY 10451, USA
    Semin Arthritis Rheum 38:188-94. 2008
  3. ncbi request reprint Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances
    Apostolos Kontzias
    Department of Medicine, Lincoln Medical and Mental Health Center, New York, New York 10451, USA
    Drugs 68:319-37. 2008
  4. doi request reprint Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities
    Petros Efthimiou
    Rheumatology Division, Lincoln Medical and Mental Health Center, Weill Cornell Medical College, 234 E 149th Street, New York, NY 10451, USA
    Rheumatol Int 30:571-86. 2010
  5. pmc T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
    Mark W Musch
    The Martin Boyer Laboratories, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    J Clin Invest 110:1739-47. 2002
  6. ncbi request reprint Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Semin Arthritis Rheum 36:168-72. 2006
  7. pmc QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?
    Petros Efthimiou
    Ann Rheum Dis 66:276. 2007
  8. ncbi request reprint Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School, and Rheumatology Clinic, University Hospital, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
    Nat Clin Pract Rheumatol 3:328-35. 2007

Collaborators

  • Joseph A Markenson
  • Apostolos Kontzias
  • Mark W Musch
  • Daniel Mamah
  • Steve D Hurst
  • David Shalowitz
  • Lara R Gawenis
  • Zheng Zhang
  • Ziad Alnadjim
  • Lane L Clarke
  • Terrence A Barrett
  • Navdha Mittal
  • William Ellsworth
  • Eugene B Chang

Detail Information

Publications8

  1. ncbi request reprint Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005
    ..Their role is currently being defined in other autoimmune disorders such as uveitis, sarcoidosis, interstitial lung disease, vasculitis, inflammatory myopathies, graft-versus-host disease, and Sjögren syndrome...
  2. doi request reprint Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature
    Petros Efthimiou
    Section of Rheumatology, Lincoln Medical and Mental Health Center, New York, NY 10451, USA
    Semin Arthritis Rheum 38:188-94. 2008
    ..Scleromyxedema is notoriously difficult to treat. Our objective was to suggest a new treatment option and to propose a novel tool, musculoskeletal ultrasound, for diagnosis and disease monitoring...
  3. ncbi request reprint Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances
    Apostolos Kontzias
    Department of Medicine, Lincoln Medical and Mental Health Center, New York, New York 10451, USA
    Drugs 68:319-37. 2008
    ..Further progress has been hampered by the rarity and heterogeneity of the disease, which has not permitted the execution of randomized controlled studies...
  4. doi request reprint Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities
    Petros Efthimiou
    Rheumatology Division, Lincoln Medical and Mental Health Center, Weill Cornell Medical College, 234 E 149th Street, New York, NY 10451, USA
    Rheumatol Int 30:571-86. 2010
    ..While the use of CAM modalities for the treatment of RA continues to increase, rigorous clinical trials examining their efficacy are necessary to validate or refute the clinical claims made for CAM therapies...
  5. pmc T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
    Mark W Musch
    The Martin Boyer Laboratories, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    J Clin Invest 110:1739-47. 2002
    ..T cell activation induces luminal fluid accumulation by increasing mucosal permeability and reducing epithelial Na(+)/K(+)-ATPase activity leading to decreased intestinal Na(+) and water absorption...
  6. ncbi request reprint Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    Semin Arthritis Rheum 36:168-72. 2006
    ....
  7. pmc QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?
    Petros Efthimiou
    Ann Rheum Dis 66:276. 2007
  8. ncbi request reprint Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Petros Efthimiou
    Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School, and Rheumatology Clinic, University Hospital, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
    Nat Clin Pract Rheumatol 3:328-35. 2007
    ..Recent advances in basic immunology have enhanced our ability to hinder the pathogenic mechanisms associated with adult-onset Still's disease and have led to a paradigm shift where targeted treatments have an increasingly important role...